Schmitz-Moormann P, Brandes J W, Jesdinsky H, Knapp M
Department of Pathology in Marburg, Municipal Hospital in Brunswick.
Pathol Res Pract. 1988 Feb;183(1):30-4. doi: 10.1016/S0344-0338(88)80155-9.
In the scope of the ECCDS, testing the efficacy of prednisolone and/or sulfasalazine in Crohn's disease, the relationships between drug regime and histology of rectal mucosa were studied. Rectal biopsies, gained at start and after termination of treatment were available in 57 patients. Additionally, biopsies of 20 normal controls were studied. The biopsies, cut completely in serial sections, were investigated by quantitative histological methods. The data were evaluated by multivariate discriminant analyses. The nearest approach of histologic pattern to normal was found after combined treatment with prednisolone and sulfasalazine, followed by prednisolone monotherapy. The effect of sulfasalazine as monotherapy was poor. The degree of normalisation in histologic pattern agrees very well with the CDAI in our subsets. Overall, effective therapy was reflected in histology of rectal mucosa by a decrease of acute inflammatory alterations and an increase of mononuclear infiltration. Only minor individual effects of the various drug regimes were found.
在欧洲克罗恩病多中心研究(ECCDS)范围内,为测试泼尼松龙和/或柳氮磺胺吡啶对克罗恩病的疗效,研究了用药方案与直肠黏膜组织学之间的关系。57例患者在治疗开始时和结束后均获取了直肠活检样本。此外,还研究了20例正常对照者的活检样本。将活检样本完全制成连续切片,采用定量组织学方法进行研究。通过多变量判别分析对数据进行评估。发现泼尼松龙与柳氮磺胺吡啶联合治疗后组织学模式最接近正常,其次是泼尼松龙单药治疗。柳氮磺胺吡啶单药治疗效果不佳。组织学模式的正常化程度与我们亚组中的临床疾病活动指数(CDAI)非常吻合。总体而言,有效治疗在直肠黏膜组织学上表现为急性炎症改变减少和单核细胞浸润增加。仅发现不同用药方案有轻微的个体效应。